Renforth Resources (CSE: RFR) (OTCQB: RFHRF), a mineral exploration company engaged in the acquisition, exploration and development of mineral properties in Canada, is reporting on the status of its wholly owned Parbec gold deposit (https://ibn.fm/WFiVB). According to the company, exploration has resumed on the project, including surface soil sampling and a prospecting campaign targeting the […]

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, was recently featured on The BioMedWire Podcast, highlighting the important results of CNM-Au8 trials for both amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), and plans for the future (https://ibn.fm/6OOO1). During the podcast, CEO […]

SOBRsafe (NASDAQ: SOBR), the provider of next-generation transdermal alcohol detection solutions, has continued to implement plans and strategies to strengthen its financial position and restructure shareholder equity throughout the second quarter of its 2024 financial year, according to its recent Q2 2024 quarterly update (https://ibn.fm/ZWPa8). In June the company entered into a Warrant Inducement agreement. […]

Canada has long been a global leader in the mining industry. Its vast, mineral-rich land, coupled with a stable political and economic climate, has fostered a thriving mining sector. Canada is the 4th largest global gold and 12th copper producer, while also ranking the among the top five producers of aluminum, cobalt, diamonds, fluorspar, gemstones, […]

The Blockchain Futurist Conference, held August 13-14 in Toronto, is Canada’s largest crypto, Web3 and blockchain conference. This year’s highlights included: Key to the event are panel discussions, which spotlight areas of interest and allow attendees to hear and meet with topic experts. These moderated discussions offer ideas and answers from business and technology leaders […]

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released findings from its applied research program that sought to evaluate the mode of action facets of its patented DehydraTECH(TM) technology and the glucagon-like peptide 1 (“GLP-1”) drug, semaglutide. The program was conducted in conjunction with the National Research Council of Canada (“NRC”), […]

Electronic monitoring (“EM”) technology innovator SuperCom (NASDAQ: SPCB) is celebrating impressive developments in 2024, reporting “substantial improvements” in its gross profit, operating income, and net income as it secures new orders and contracts from government and judicial system clients. SuperCom’s technology development and deployment are strategically focused on providing EM tools for tracking offenders supervised […]

In 1901, the then-45-year-old Burberry, now a renowned British luxury fashion house, ran a public competition seeking a winning entry that would become the new logo for the company. The winning entry was the equestrian knight design (“EKD”), a testimony to the company’s relationship with its communities. The EKD depicted an armor-clad knight riding a […]

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), offered key business updates and announced financial results for the second quarter ended June 30, 2024. The company reported productive recent months, with encouraging data on lead compound buntanetap’s performance […]

InMed Pharmaceuticals (NASDAQ: INM), a biopharmaceutical company focused on developing proprietary small molecule drug candidates for diseases with high unmet needs, has announced promising outcomes from a long-term preclinical study of its Alzheimer’s Disease (“AD”) drug candidate, INM-901. These new findings confirm and expand upon results from a previous short-term pilot study (https://ibn.fm/eASUI). The long-term […]